The effect of Interleukin-24 (IL-24) on CSCs and CAR-T cell therapy.
Pharvaris soars on mid-stage data for severe swelling condition, raises $300M
Pharvaris immediately announced the pricing of a $300 million offering on Wednesday after disclosing positive mid-stage data on its oral drug for a rare, inherited